Trial · NCT02974868
Adverse events1,605
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,605
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Acne | Skin and subcutaneous tissue disorders | Treatment Period-Placebo | 2 | 47 | |
| other | Acne | Skin and subcutaneous tissue disorders | Treatment Period-PF-06651600 | 5 | 48 | |
| other | Acne | Skin and subcutaneous tissue disorders | Treatment Period-PF-06700841 | 5 | 47 | |
| other | Acne | Skin and subcutaneous tissue disorders | Single Blind Extension-Active Non-responders on PF-06651600 | 0 | 16 | |
| other | Acne | Skin and subcutaneous tissue disorders | Single Blind Extension-Placebo Non-responders on PF-06651600 | 0 | 17 | |
| other | Acne | Skin and subcutaneous tissue disorders | Single Blind Extension-Active Non-responders on PF-06700841 | 0 | 5 | |
| other | Acne | Skin and subcutaneous tissue disorders | Single Blind Extension-Placebo Non-responders on PF-06700841 | 1 | 12 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Non-Retreated PF-06651600 Responders in Withdrawal Segment | 0 | 8 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Retreated PF-06651600 Responders in Withdrawal Segment | 0 | 14 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Non-Retreated PF-06700841 Responders (Withdrawal Segment) | 0 | 9 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Retreated PF-06700841 Responders in the Withdrawal Segment | 0 | 14 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Retreated PF-06651600 Responders in Retreatment Segment | 0 | 14 | |
| other | Acne | Skin and subcutaneous tissue disorders | SBE-Retreated Responders on PF-06700841 in Retreatment Segment | 0 | 15 | |
| other | Acne | Skin and subcutaneous tissue disorders | Cross Over Extension-PF-06651600 | 0 | 5 | |
| other | Acne | Skin and subcutaneous tissue disorders | Cross Over Extension-PF-06700841 | 1 | 18 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Treatment Period-Placebo | 0 | 47 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Treatment Period-PF-06651600 | 0 | 48 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Treatment Period-PF-06700841 | 0 | 47 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Single Blind Extension-Active Non-responders on PF-06651600 | 0 | 16 | |
| other | Dermatitis | Skin and subcutaneous tissue disorders | Single Blind Extension-Placebo Non-responders on PF-06651600 | 0 | 17 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02974868/events